Pfizer gets USFDA nod for COVID vaccine for kids

The U.S. Food and Drug Administration has authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA's thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group.

For more details, check out the full story on the link below:

FDA Okays Emergency Authorization Of Pfizer COVID-19 Vaccine For Kids Between 5 To 11 Years